Study of in-hospital protein drug supply chain

• At: Seville (Spain) (2022)
• Type: Poster
• Poster code: HPS-101
• By: PAULSSON, Mattias (Sanofi Formulation & Process Development, Germany)
• Co-author(s): Clàudia Sabaté Martínez, Uppsala University, Dep Children's and Women's Health (Uppsala University, Dep Children's and Women's Health, Uppsala, Sweden)
  Dr Marika Rosenberger, Biologics Drug Product Development & Manufacturing (Sanofi Formulation & Process Development, Frankfurt am Main, Germany)
  Dr Mattias Paulsson, Deputy Chief Pharmacist (Uppsala University Hospital, Uppsala, Sweden)
  
• Abstract:

  Background information
  Protein drug products (s such as monoclonal antibodies, enzymes, coagulation factors…) have dramatically improved the lives of people with immune-system diseases, rare diseases for example rheumatology or extended the survival rate of people in treatment for cancer. However, stresses such as vigorous shaking and vibration..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login